| First Author | DiMario JX | Year | 2018 |
| Journal | Am J Pathol | Volume | 188 |
| Issue | 5 | Pages | 1263-1275 |
| PubMed ID | 29458012 | Mgi Jnum | J:261103 |
| Mgi Id | MGI:6154407 | Doi | 10.1016/j.ajpath.2018.01.014 |
| Citation | DiMario JX (2018) KLF10 Gene Expression Modulates Fibrosis in Dystrophic Skeletal Muscle. Am J Pathol 188(5):1263-1275 |
| abstractText | Dystrophic skeletal muscle is characterized by fibrotic accumulation of extracellular matrix components that compromise muscle structure, function, and capacity for regeneration. Tissue fibrosis is often initiated and sustained through transforming growth factor-beta (TGF-beta) signaling, and Kruppel-like factor 10 (KLF10) is an immediate early gene that is transcriptionally activated in response to TGF-beta signaling. It encodes a transcriptional regulator that mediates the effects of TGF-beta signaling in a variety of cell types. This report presents results of investigation of the effects of loss of KLF10 gene expression in wild-type and dystrophic (mdx) skeletal muscle. On the basis of RT-PCR, Western blot, and histological analyses of mouse tibialis anterior and diaphragm muscles, collagen type I (Col1a1) and fibronectin gene expression and protein deposition were increased in KLF10(-/-) mice, contributing to increased fibrosis. KLF10(-/-) mice displayed increased expression of genes encoding SMAD2, SMAD3, and SMAD7, particularly in diaphragm muscle. SMAD4 gene expression was unchanged. Expression of the extracellular matrix remodeling genes, MMP2 and TIMP1, was also increased in KLF10-deficient mouse muscle. Histological analyses and assays of hydroxyproline content indicated that the loss of KLF10 increased fibrosis. Dystrophic KLF10-null mice also had reduced grip strength. The effects of loss of KLF10 gene expression were most pronounced in dystrophic diaphragm muscle, suggesting that KLF10 moderates the fibrotic effects of TGF-beta signaling in chronically damaged regenerating muscle. |
